New research from the Royal Veterinary College (RVC) has identified porcupine inhibition—a strategy that blocks a key bone-related signaling pathway (Wnt)—as a promising pharmacological treatment for severe sclerosteosis.
Porcupine inhibition represents a promising treatment for sclerosteosis patients
